Catherine Kate Hill

Ms Hill is a non-executive director of ASX listed companies and has experience in both technology companies and the biotech and medical devices sectors. In addition, she has experience of other listing exchanges including Nasdaq (US) and AIM (UK). She previously spent 20 years as an audit partner at Deloitte, serving both ASX-listed and privately owned clients. She has worked in regulated environments, including assisting with Initial Public Offerings, capital raising, and general compliance, as well as operating in an audit environment.